The global diabetes market is experiencing exponential expansion driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading manufacturers of GLP-1 receptor agonists, a https://tirzepatidepharma.com/index.php/product/eflornithine-13-9-gel/